Influenza A viruses remain a global threat to human health, with continued pandemic potential. In this Review, we discuss our current understanding of the optimal immune responses that drive recovery ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu strains. In ...

Oral Rotavirus vaccines have reduced disease globally but multiple factors in low- and middle-income countries (LMICs) diminish vaccine effectiveness and disease burden remains high. A convening of ...

In the span of just a few weeks in February and March, qualified immunity made headlines in three very different ways. A civil-rights organization publicly urged New York’s governor to abolish it ...

Detailed immune profiling in long-term care populations reveals that SARS-CoV-2 vaccines and infections drive powerful virus-specific responses while leaving lifelong common cold immunity largely ...

The fatality rate for H5N1 highly pathogenic avian influenza in humans has historically been high, with more than half of people dying. Why, then, is the current H5N1 bird flu outbreak—which has ...

A new malaria vaccine achieves an unparalleled 89% efficacy by targeting late-liver-stage antigens, unlocking new horizons in the fight against global disease. Study: Safety and Efficacy of ...